Press release
Psoriasis Treatment Market Perceives Massive collections with a Striking CAGR of 7.3% by 2022
Psoriasis Treatment Market widely Available. Psoriasis Treatment Market is Increasing awareness, rise in risk factors such as autoimmune diseases, diabetes etc. and greater exposure to environmental factors such as chemicals, allergens etc. Psoriasis is a chronic non-contagious disease in which a person’s immune system sends faulty signals directing skin cells to grow too quickly.Psoriasis affects mostly knees, elbows, and scalp, but other body parts may also be affected. Thus, it has a heavy negative effect on the quality of life and results in social stigma. New skin cells forms in days rather than weeks resulting in their pilling up on the surface of the skin, causing patches of psoriasis. Most of the time it also affects fingers and nails resulting in painful disfiguration and partial disability.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2769 .
Psoriasis Treatment Market was valued to be US$7.0 billion in 2016 and is expected to reach US$10.68 billion by 2022. Thus the market is expected to grow at a CAGR of 7.3% from 2016 to 2022.
According to the World Health Organization (WHO), 1.3% to 34.7% of individuals with psoriasis develop chronic psoriatic arthritis which may lead to joint deformations and disability. From 4.2% to 69% of all patients suffering from psoriasis develop nail changes. WHO also predicts that psoriasis affects about 100 million people with prevalence rates ranging from 0.09% to 11.43% in different countries. Plaque psoriasis is the most common form of psoriasis affecting 90% of all cases of psoriasis.
Competitors Companies for Global Psoriasis Treatment Market:
Merck and Co. Inc, AbbVie and Amgen and Eli Lilly, Novartis International AG, Johnson & Johnson, Pfizer Inc.
Study Objectives Global Psoriasis Treatment market:
To provide country level analysis of the market with respect to the current market size and future growth prospect.
To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the global psoriasis treatment market.
To analyze the market based on various analyses which includes price analysis, supply chain analysis, Porters Five Force analysis etc.
To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries including Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide insights about factors affecting the market growth.
Browse Full Report @ https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769 .
Market Segments:
Global psoriasis treatment market has been segmented on the basis of mechanism of action, route of administration and by drug types. Although it can occur at any age but most commonly it occurs in the age group of 50–70. The exact cause and etiology of psoriasis is still unknown but usually auto-immunity, genetics and environmental factors are involved. Psoriasis is also associated with a host of co-morbidities such as psoriatic arthritis, ophthalmologic pathologies, diabetes, inflammatory bowel disease etc.
Regional Analysis of Global Psoriasis Treatment Market
Worldwide North America is the largest market of global psoriasis treatment. Europe is the second largest market for global psoriasis treatment. However the developing market is Asia Pacific that will be the fastest growing region and will be the key to the future.
Rise in screening and growing prevalence of psoriasis remains the most critical market driving factor of the global psoriasis treatment market. In general an upward trend is observed in several countries throughout the world. For example data from the national health and nutrition examination survey revealed that in United States prevalence of psoriasis increased from 1.62% to 3.10% from 2004 to 2010.
Get Discount @ https://www.marketresearchfuture.com/check-discount/2769 .
List of Figures:
Figure 1 research process
Figure 2 porters five forces model
Figure 3 global psoriasis treatment market, by mechanism of action
Figure 4 global psoriasis treatment market, by route of administration
Figure 5 global psoriasis treatment market, by drug types
Figure 6 global psoriasis treatment market, by region
Figure 7 global psoriasis treatment market: company share analysis, 2015 (%)
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Treatment Market Perceives Massive collections with a Striking CAGR of 7.3% by 2022 here
News-ID: 811630 • Views: …
More Releases from Market Research Future
Salicylic Acid Market Analysis: Industry Growth at a 7.0% CAGR During 2026-2035
The global salicylic acid market is experiencing robust growth, driven by its essential role in dermatology, cosmetics, and pharmaceutical applications. According to a comprehensive report by Market Research Future, the market was valued at USD 130.12 million in 2025 and is projected to reach USD 254.83 million by 2035, advancing at a compound annual growth rate of 7.0%. This expansion reflects the compound's established regulatory status, increasing consumer demand for…
Specialty Silica Market Set for Steady Growth, Surpassing USD 8,893 Million by 2 …
The global specialty silica market is experiencing steady growth, driven by its indispensable role in high-performance applications ranging from green tires to semiconductor manufacturing. According to a comprehensive report by Market Research Future, the market was valued at USD 5,920 million in 2025 and is projected to reach USD 8,893 million by 2035, advancing at a compound annual growth rate of 4.15%. This trajectory reflects a structural shift in industrial…
Lubricant Additives Market Outlook: Capitalising on High-Performance Formulation …
The global lubricant additives market is navigating a period of profound transformation, driven by tightening emissions regulations, the rise of electric vehicles, and a relentless push for greater fuel efficiency. According to a comprehensive report by Market Research Future, the market was valued at USD 19.55 billion in 2025 and is projected to reach USD 27.71 billion by 2035, advancing at a compound annual growth rate of 3.55%. This growth…
Emulsion Polymers Market: Navigating the Shift Toward Sustainable, High-Performa …
The global emulsion polymers market is on a steady growth trajectory, driven by a powerful combination of environmental regulations, technological innovation, and large-scale infrastructure investment. According to a comprehensive report by Market Research Future, the market was valued at USD 31.15 billion in 2025 and is projected to reach USD 54.98 billion by 2035, reflecting a compound annual growth rate of 5.85%. This expansion is primarily fueled by the accelerating…
More Releases for Psoriasis
Psoriasis Clinical Trial Pipeline Analysis: 65+ Key Companies Shaping the Future …
DelveInsight's Psoriasis Pipeline Insight 2026 report provides comprehensive global coverage of available, marketed, and pipeline psoriasis therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the psoriasis pipeline domain.
Key takeaways from the Psoriasis Clinical Trial Landscape Report
• DelveInsight's psoriasis pipeline report depicts a robust space with 65+ active players working to develop 75+ pipeline therapies for psoriasis treatment.
• Key…
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
